OncoDxRx’s Post

View organization page for OncoDxRx, graphic

1,386 followers

Using PGA to identify potent and selective drugs for the treatment of cancer Across the world, cancer poses serious threats to everyone’s health, and overall quality of life. In order to identify potential effective drugs for new therapeutics, the research team at OncoDxRx leveraged its proprietary gene expression-driven drug identification platform, PGA, to facilitate clinical decision-making on three types of cancers, including lung, pancreatic, and breast cancer. Using cell-free mRNA based gene expression signature strategies and applying rigorous filters for similarity and selectivity, OncoDxRx scientists identified an array of existing drugs which the patient is likely to respond to. This knowledge provided clinical guidance for treatment strategy optimization, leading to better patient outcome. The innovative PGA test has not only presented a breakthrough for effective drug identification but has also led to the revolution of drug repurposing. PGA expands OncoDxRx’s one-of-a-kind liquid biopsy pipelines and paves the way toward a safer, more effective therapeutic future for patients battling lung, pancreatic, and breast cancers. #opportunities #strategy #programming #design #team #research #data #health #development #collaboration #projects #testing #immunotherapy #cancer #technology #biotechnology #healthcare #medicine #oncology #precisionmedicine #liquidbiopsy #rna #dna #venturecapital #startup #immunooncology #tcells #innovation #growth #tech #lifesciences #biopharma #oncodxrx

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics